Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Batra, 1991, Isolation and characterization of a complementary DNA (PD-1) differentially expressed by human pancreatic ductal cell tumors, Cell Growth Differ., 2, 385

Batra, 1991, Molecular cloning and sequence analysis of the human ribosomal protein S16, J. Biol. Chem., 266, 6830, 10.1016/S0021-9258(20)89575-1

Batra, 1994, Mouse-/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization, Hybridoma, 13, 87, 10.1089/hyb.1994.13.87

Beidler, 1988, Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen, J. Immunol., 141, 4053

Blottiere, 1990, Immunoglobulin class and immunoglobulin g subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients, Cancer Res., 50, 1051s

Bourdon, 1983, Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody, Cancer Res., 43, 2796

Bourdon, 1984, Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis, Anticancer Res., 4, 133

Bullard, 1986, In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies, J. Neurosurg., 64, 257, 10.3171/jns.1986.64.2.0257

Calame, 1985, Mechanisms that regulate immoglobulin gene expression, Ann. Rev. Immunol., 3, 159, 10.1146/annurev.iy.03.040185.001111

Chirgwin, 1979, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18, 5294, 10.1021/bi00591a005

Enghild, 1991, Chondroitin 4-sulfate covalently crosslinks the chains of the human blood protein pre-α-inhibitor, J. Biol. Chem., 266, 747, 10.1016/S0021-9258(17)35235-3

Erickson, 1989, Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors, Annu. Rev. Cell Biol., 5, 71, 10.1146/annurev.cb.05.110189.000443

Falkner, 1984, Correct transcription of an immunoglobulin κ gene requires an upstream fragment containing conserved sequence elements, Nature, 310, 71, 10.1038/310071a0

Fraker, 1978, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril, Biochem. Biophys. Res. Commun., 80, 849, 10.1016/0006-291X(78)91322-0

Gillies, 1989, High-level expression of chimeric antibodies using adapted cDNA variable region cassettes, J. Immunol. Methods, 125, 191, 10.1016/0022-1759(89)90093-8

Hardman, 1989, Generation of a recombinant mouse-human chimeric monoclonal antibody directed against human carcinoembryonic antigen, Int. J. Cancer, 44, 424, 10.1002/ijc.2910440308

Hoffman, 1990, Anticipating, recognizing, and preventing hazards associated with in vivo use of monoclonal antibodies: special considerations related to human anti-mouse antibodies, Cancer Res., 50, 1049s

Hoogenboom, 1990, Cloning and expression of a chimeric antibody directed against the human transferrin receptor, J. Immunol., 144, 3211

Ibrahim, 1993, Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma, Hum. Pathol., 24, 982, 10.1016/0046-8177(93)90112-T

Joho, 1984, Evolution of a multigene family of VK germ line genes, EMBO J., 3, 185, 10.1002/j.1460-2075.1984.tb01782.x

Jones, 1989, A detailed structural model of cytotactin: protein homologies, alternative RNA splicing, and binding regions, 86, 1905

Khaw, 1991, Gamma imaging with negatively charge-modified monoclonal antibody: modifications with synthetic polymers, J. Nucl. Med., 32, 1742

Khazaeli, 1992, Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody, J. Clin. Immunol., 12, 116, 10.1007/BF00918141

Lee, 1988, Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model, Cancer Res., 48, 559

Lee, 1988, Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6, Cancer Res., 48, 2904

Lightner, 1989, Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy, J. Cell. Biol., 108, 2483, 10.1083/jcb.108.6.2483

Liu, 1987, Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells, 84, 3439

LoBuglio, 1989, Mouse/human chimeric monoclonal antibody in man: kinetics and immune response, 86, 4220

Meredith, 1991, Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody, J. Nucl. Med., 32, 1162

Morrison, 1985, Transfectomas provide novel chimeric antibodies, Science, 229, 1202, 10.1126/science.3929380

Morrison, 1984, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains, 81, 6851

Morrison, 1988, Production and characterization of genetically engineered antibody molecules, Clin. Chem., 34, 1668, 10.1093/clinchem/34.9.1668

Murphy-Ullrich, 1991, Focal adhesion integrity is down-regulated by the alternatively spliced domain of human tenascin, J. Cell Biol., 115, 1127, 10.1083/jcb.115.4.1127

Nakashima, 1991, Recombinant human-mouse chimeric monoclonal antibody specific for human adenocarcinoma associated antigen, Hybridoma, 10, 1, 10.1089/hyb.1991.10.1

Nies, 1991, The complete cDNA sequence of human hexabrachion (tenascin), J. Biol. Chem., 266, 2818, 10.1016/S0021-9258(18)49920-6

Nishimura, 1987, Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen, Cancer Res., 47, 999

Sahagan, 1986, A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen, J. Immunol., 137, 1066

Schold, 1983, Growth, morphology, and serial transplantation of anaplastic human gliomas in athymic mice, J. Neurooncol., 1, 5, 10.1007/BF00153635

Schold, 1993, Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma, Invest. Radiol., 28, 488, 10.1097/00004424-199306000-00003

Sun, 1987, Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A, 84, 214

Wikstrand, 1987, Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model, J. Neuroimmunol., 15, 37, 10.1016/0165-5728(87)90005-1

Zalutsky, 1989, Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies, Cancer Res., 49, 2807

Zalutsky, 1990, Monoclonal antibody and F(ab′)2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration, Cancer Res., 50, 4105